CorrectSequence Therapeutics’ tBE Tech Wins USPTO Patent for Gene Editing
Shanghai-based gene editing firm CorrectSequence Therapeutics announced it has received a patent from the United...
Gene therapy
GeneRulor Medical Technology Raises Funds for Gene Editing Diagnostics
China-based gene editing specialist ZhuHai GeneRulor Medical Technology Co., Ltd. reportedly raised “tens of millions”...
GenScript Biotech’s ProBio Subsidiary Receives USD 37.25M Investment from Zhenjiang Gaoxin
Hong Kong-based Contract Research Organization (CRO) GenScript Biotech Corporation (HKG: 1548) announced that Zhenjiang Gaoxin...
BDgene Advances CRISPR-Based BD111 for Herpes Keratitis with IND Filing
Shanghai BDgene Technology Co., Ltd has completed efficacy and preliminary safety studies for BD111, its...
MegaRobo Secures USD 300 Million in Series C Round Led by Goldman Sachs
Beijing-based MegaRobo Technologies, a company applying robotics and artificial intelligence (AI) in the life sciences...